New laser procedure shows promise for glaucoma patients

NCT ID NCT05654493

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study from the Mayo Clinic tested a laser procedure called MP-TSCPC in 65 glaucoma patients to see how well it lowers eye pressure. Researchers tracked patients for one year after the procedure, measuring changes in eye pressure, medication use, and vision. The goal was to evaluate if this laser treatment is a safe and effective option for managing glaucoma.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MicroPulse Transscleral Laser Therapy (MP-TSCPC) using a revised P3 Delivery Device

What this could lead to

If successful, this laser procedure could offer a safe and effective way to lower eye pressure in glaucoma patients, potentially reducing the need for daily eye drops.

What could go wrong

This is a small, single-center observational study with no comparison group. The results may not apply to all glaucoma patients, and the procedure carries risks like inflammation or temporary vision changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic Florida

    Jacksonville, Florida, 32224, United States